Gyre Therapeutics (GYRE) Debt Ratio (2009 - 2017)
Gyre Therapeutics' Debt Ratio came in at 0.13 for Q4 2017, down 74.7% from 0.51 a year earlier and down 19.3% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Debt Ratio (2009 - 2017) Analysis & Trends
Going back to Q4 2010, Gyre Therapeutics' Debt Ratio data covers 25 quarters.
- Going back by year, Debt Ratio was 0.51 in FY2016 (+5.0%), 0.49 in FY2015 and 0.01 in FY2013 (-25.7%).
- The Q4 2017 figure represents the lowest quarterly Debt Ratio since Q3 2014.
- Year-over-year, Debt Ratio has declined for four consecutive quarters, with an average decline of 34.1% over the last six quarters.
- The fastest year-over-year change in Debt Ratio over five years came in Q3 2016 (growth of 23.2%), and the weakest in Q4 2017 (a decline of 74.7%).
- Business Quant data shows GYRE's Debt Ratio at 0.16 (Q3 2017), 0.15 (Q2 2017) and 0.44 (Q1 2017) in the three quarters before Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 0.33 |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.23 |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 0.55 |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 0.41 |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -0.06 |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 0.56 |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 0.51 |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 0.31 |
| 10 | Gyre Therapeutics | 487.81 Mn | 295.13 Mn | 30.99 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 0.13 |
| Sep 30, 2017 | 0.16 |
| Jun 30, 2017 | 0.15 |
| Mar 31, 2017 | 0.44 |
| Dec 31, 2016 | 0.51 |
| Sep 30, 2016 | 0.57 |
| Jun 30, 2016 | 0.53 |
| Mar 31, 2016 | 0.50 |
| Dec 31, 2015 | 0.49 |
| Sep 30, 2015 | 0.47 |
| Sep 30, 2014 | 0.00 |
| Jun 30, 2014 | 0.01 |
| Mar 31, 2014 | 0.01 |
| Dec 31, 2013 | 0.01 |
| Sep 30, 2013 | 0.01 |
| Jun 30, 2013 | 0.01 |
| Mar 31, 2013 | 0.01 |
| Dec 31, 2012 | 0.01 |
| Sep 30, 2012 | 0.01 |
| Jun 30, 2012 | 0.01 |
API Access
Gyre Therapeutics Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();